Request For Report Sample @ https://www.coherentmarketinsights.com/insight/request-sample/2394
Many biopharmaceutical companies are entering into developing plant-made pharmaceuticals using various plants such as tobacco, duckweed, moss, alfalfa, and other plants, which is expected to propel growth of the plant-based biologics market. For instance, in September 2015, LeafBio, Inc., the commercial partner of Mapp Biopharmaceutical, Inc. (Mapp), was granted fast track designation by the U.S. Food and Drug Administration (FDA) for their plant-made drug called ZMapp for the treatment of Ebola virus disease.
However, stringent regulatory guidelines for the production of plant-based biologics is one of the major factors restraining growth of the plant-based biologics market. Moreover, concern regarding contamination and environmental risks is another factor restraining growth of the market.
Major players operating in the global plant-based biologics market include PlantForm, IBio Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience, Medicago Inc., Greenovation Biotech GmbH, Kentucky BioProcessing, PhycoBiologics Inc., Synthon, Fraunhofer IME, Healthgen, PlanetBiotechnology, and Icon Genetics GmbH. Key players in plant-based biologics market are focused on adopting market strategies such as collaborations, mergers & acquisitions, and new product development, in order to retain dominant position in the market.
For instance, in August 2017, Japanese company named Denka acquired German plant biotech Icon Genetics Inc. for approximately US$ 85.0 million. This acquisition will help Denka to focus on research and development in the vaccines and diagnostic reagents business and to continue development of new biopharmaceuticals, including biosimilar and ‘biobetter’ antibodies.
Plant-based biologics is expected to be the next major commercial development in the field of biotechnology. Some of the advantages offered in terms of product safety, production scale and economy, ease of storage, and distribution cannot be fulfilled at same time by any other current commercial system. They also provide the opportunity to supply low-cost drugs and vaccines to the emerging economies.
Usage of plant-based cell line instead of mammal cell lines to produce biologic drugs came to the forefront when various companies were trying to scale up the alternative process in an effort to produce treatment for Ebola. The approval of the first plant-made biologic (PMB) - taliglucerase alfa for injection by the U.S. Food and Drug Administration (USFDA) for treating Gaucher's disease in 2012 proclaimed a new era for PMBs and triggered the innovation in the field of biopharmaceuticals.
Read Full Report with TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/2394
On the basis of plant system, the global plant-based biologics market is segmented into:
On the basis of source, the global plant-based biologics market is segmented into:
On the basis of geography, the global plant-based biologics market is segmented into:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,, #3200, Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Plant-based Biologics here
News-ID: 1578714 • Views: 755
More Releases from Coherent Market Insights
Regulatory Information Management Market 2022 Global Competition by Opportunity …
Regulatory information management market in Asia Pacific is expected to exhibit a significant CAGR over the forecast period (2018 - 2026). Summary of the Report - CMI's latest report, global "Regulatory Information Management Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Acuta, Llc, Parexel, Computer Sciences Corp (CSC), Aris Global, Virtify,
Medium Voltage Vacuum Contactors Market Investment Activity From Established Com …
Summary of the Report - CMI's latest report, global "Medium Voltage Vacuum Contactors Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Eaton, ABB, Toshiba, Siemens, General Electric, Joslyn Clark, Mitsubishi Electric, Arteche, and Tavrida Electric.. ▪ Profiles of 5 leading companies in the industry - overview, key strategies, financials, and products ▪
Connected Logistic Market 2028: This Report Explains How This Industry Will Witn …
Summary of the Report - CMI's latest report, global "Connected Logistic Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - AT&T Inc., IBM Corporation, Intel Corporation, SAP SE, Infosys Limited, Cisco Systems Inc., HCL Technologies Limited, Eurotech S.P.A., Microsoft, oracle, Cloud Logistics, Zebra technologies, ORBCOMM, and GT Nexus.. Profiles of 5 leading
Alloy Market for Automotive 2028: This Report Explains How This Industry Will Wi …
Summary of the Report - CMI's latest report, global "Alloy Market for Automotive" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - ThyssenKrupp AG, Sumitomo Metal Corporation, AMG Advanced Metallurgical Group, UACJ Corporation, Arcelormittal SA, Nippon Steel & Sumitomo Metal Corp., Constellium N.V., Alcoa Inc., Norsk Hydro ASA, and Novelis Inc.. Profiles of
More Releases for Biologics
Global Biologics Size and Segments
The Business Research Company’s global Biologics market report, covers the year-on-year growth of the global Biologics market historic and forecast growth. It also includes chapters on the Biologics market trends, Biologics geographical analysis, Biologics driver and restraints, and Biologics leading competitors’ revenues, profiles and market shares. Order The Global Biologics Market Report At: https://www.thebusinessresearchcompany.com/report/biologics-global-market-opportunities-and-strategies-to-2021 Global Biologics Market Segments The Biologics industry can be further categorized into -monoclonal antibodies (mAbs) market, therapeutic proteins market,
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Oral Biologics Market Opportunity Analysis, 2018-2026
Oral biologics represent a novel category of drugs, which is gaining traction in the last few decades. Biologic therapeutics has proven to be a highly effective treatment for various chronic ailments, such as diabetes, plaque psoriasis, arthritis, plaque psoriasis, Crohn’s disease, and ulcerative colitis. The major concern regarding oral biologics is to protect the protein from degradation and digestion in the gastrointestinal tract. The first products were mostly insulin-related, novel
Spine Biologics Market Industry Analysis
Spine Biologics Market was worth USD 2.07 billion in 2016 and estimated to be growing at a CAGR of 4.4%, to reach USD 2.56 billion by 2021. Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through inflammatory stage, repair stage, and remodeling stage. Therefore, surge in the number of
Biologics Market | Key Opportunities And Forecast 2024
The Global Market For Biologics features a fragmented competitive landscape with stakeholders being some of the world’s most influential pharmaceutical companies and several domestic companies, which are vying for a share in the highly profitable market, observes Transparency Market Research (TMR) in a recent report. “A popular trend in the market is strategic mergers and acquisitions, with big companies wanting to expand their services and manufacturing units globally and enhancing
Biologics Market : Analysis & Trends 2024
Global Biologics Market: Scope and Methodology This report provides forecast and analysis of the global biologics market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook for biologics revenue annually. It includes drivers and restraints of the global biologics market and their impact on each